Dr. Rauch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- Baylor College of MedicineResidency, Radiology-Diagnostic, 2003 - 2008
- Tbilisi State Medical UniversityClass of 1988
Certifications & Licensure
- TX State Medical License 2008 - 2026
- American Board of Radiology Diagnostic Radiology
Clinical Trials
- DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer Start of enrollment: 2016 Nov 07
- Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue Start of enrollment: 2017 Jun 14
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Combining Biology-based and MRI Data-driven Modeling to Predict Response to Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.Casey E Stowers, Chengyue Wu, Zhan Xu, Sidharth Kumar, Clinton Yam
Radiology. Artificial Intelligence. 2025-01-01 - Feasibility of breast conserving surgery alone in HER2-positive exceptional responders to neoadjuvant systemic therapy.Melissa P Mitchell, Simona F Shaitelman, Benjamin D Smith, Savitri Krishnamurthy, Vicente Valero
European Journal of Surgical Oncology. 2024-12-01 - Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study.Clinton Yam, Miral Patel, Holly A Hill, Ryan Sun, Roland L Bassett Jr
Cancer Research Communications. 2024-10-01
Press Mentions
- MRI Model Predicts Treatment Response in Breast Cancer PatientsSeptember 3rd, 2024
- Researchers in Texas Continue Collaboration on Oncological Data and Computational ScienceOctober 13th, 2022
- MRI Biomarker Data Helps Predict Breast Cancer Treatment ResponseJuly 19th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: